Skip to main content
Clinical Trials/JPRN-UMIN000009526
JPRN-UMIN000009526
Recruiting
Phase 2

Exploratory study to determine predictive factors of effectiveness of nab-paclitaxel in breast cancer (Expect study) - Exploratory study to determine predictive factors of effectiveness of nab-paclitaxel in breast cancer (Expect study)

Toho University School of Medicine, Medical Center, Ohashi Hospital0 sites40 target enrollmentDecember 11, 2012
ConditionsBreast cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Breast cancer
Sponsor
Toho University School of Medicine, Medical Center, Ohashi Hospital
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 11, 2012
End Date
December 31, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Toho University School of Medicine, Medical Center, Ohashi Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.History of hypersensitivity reaction 2\.HER2 positive confirmed by IHC or FISH 3\. Active another cancer 4\.Other severe complications, such as infection, diarrhea, intestinal tract paralysis, ileus, uncontrollable diabetes,uncontrollable angina, myocardial infarction within 6 months, heart failure, Pulmonary fibrosis or interstitial pneumonia, cerebrovascular disorder 5\.With symptomatic brain cancer 6\.With mental disorder which become problem on clinical practice 7\.With serious bone marrow suppression, a renal damage, a liver damage 8\.With serious pleural effusion or ascites 9\.With infection or febrile infection 10\. Hypersensitivity reaction of nab\-paclitaxel or paclitaxel 11\.During administration of flucytosine, phenytoin, warfarin potassium 8\. Physician judged improper to entry this trial

Outcomes

Primary Outcomes

Not specified

Similar Trials